Kenneth Fan

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation. eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.

solos® is originated from Kopin Corporation (NASDAQ: KOPN), a leading provider of wearable computing headsets solutions for the U.S. military and enterprise markets. Comprised of a group of experienced engineers and eyewear architects, solos® is expertise in innovating eyewear with over 30 patents and is well-known for its debuted Solos Sports, the US Olympian-Approved smart cycling glasses. Today, solos® is dedicated to designing smart eyewear to every one of you. As the everyday eyewear, solos® provides comfy experience with the patented Whisper™ Audio Technology for superb noise cancellation and audio quality. Our eyewear are ergonomically designed, lightweight and flexible, it allows to change frames from a versatile selection. If you enjoy smart living, solos® smart eyewear will be your perfect all-day-long companion.

Addgene is a nonprofit plasmid repository located in Watertown, Massachusetts. Addgene’s mission is to accelerate research and discovery by improving access to useful research materials and information. Addgene facilitates the sharing of high-quality scientific materials, research reproducibility, and open science by archiving and distributing DNA-based research reagents and associated data to scientists worldwide. Addgene’s repository contains over 70,000 plasmids, including special collections on CRISPR, fluorescent proteins, chemogenetics, optogenetics, and viral plasmids. All plasmids in Addgene’s repository were deposited by your scientific colleagues from around the world. There is no cost for scientists to deposit plasmids, which saves time and money associated with shipping plasmids themselves. All plasmids are fully sequenced for validation and sequencing data is openly available. Addgene also provides ready-to-use AAV and lentiviral preparations of commonly requested plasmids as a service to scientists. Addgene offers free online educational resources and protocols about molecular biology topics such as common vector backbones, cloning, CRISPR, AAV and lentivirus production, and science careers. These resources include the Addgene blog, eBooks, guides, videos, and a podcast series.

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation. eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.

solos® is originated from Kopin Corporation (NASDAQ: KOPN), a leading provider of wearable computing headsets solutions for the U.S. military and enterprise markets. Comprised of a group of experienced engineers and eyewear architects, solos® is expertise in innovating eyewear with over 30 patents and is well-known for its debuted Solos Sports, the US Olympian-Approved smart cycling glasses. Today, solos® is dedicated to designing smart eyewear to every one of you. As the everyday eyewear, solos® provides comfy experience with the patented Whisper™ Audio Technology for superb noise cancellation and audio quality. Our eyewear are ergonomically designed, lightweight and flexible, it allows to change frames from a versatile selection. If you enjoy smart living, solos® smart eyewear will be your perfect all-day-long companion.

NextGen Venture Partners works with over 1,800 Venture Partners to invest $1 million in seed stage companies and $2 million to $10 million in companies with more than $10 million in revenue. Our Venture Partners are top founders and innovation executives across the country whose expertise and connections help NextGen accelerate the growth of our portfolio companies.

With four campuses in Massachusetts, Tufts is a research university committed to helping students and faculty generate bold ideas, innovate, and become active citizens of the world. Tufts​ unique combination of research and liberal arts attracts students, faculty, and staff who thrive in an environment of curiosity, creativity and engagement.